Kezar Life Sciences Inc (KZR) Stock Analysis

Kezar Life Sciences Inc (KZR) is a publicly traded company in the HEALTHCARE sector. It trades at $7.29. This page summarizes the public market data, fundamentals, and frequently asked questions for KZR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.29

Market Sentiment

Kezar Life Sciences Inc currently has a Neutral sentiment score of 0.03.

About Kezar Life Sciences Inc

Kezar Life Sciences, Inc. is a promising clinical-stage biotechnology company headquartered in South San Francisco, California, focused on the development of innovative small molecule therapies targeting immune-mediated diseases and cancer. Leveraging its proprietary drug discovery platform, Kezar is committed to addressing significant unmet medical needs with a strong and diverse pipeline of candidates in various stages of clinical development. This strategic focus not only positions the com...

GNG Research Analysis

GNG Research scores Kezar Life Sciences Inc (KZR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for KZR.

Frequently Asked Questions

Does KZR pay dividends?

Kezar Life Sciences Inc (KZR) does not currently pay a regular dividend.